Brief: Karyopharm Therapeutics Q2 Net Income USD -32.63 Million
Aug 02 (Reuters) - Karyopharm Therapeutics Q2 operating expenses USD 67.152 million. * Q2 product revenue USD 28.46 million * Q2 operating income USD -29.573 million * Outlook FY Revenue USD 145-160 Million